Molecular Docking Approach for Prediction of Chromatographic Chiral Separation of Ketorolac Using AGP Column

Abstract:

Prediction of chiral separation of R- and S-ketorolac has been carried out using a molecular docking approach. Geometry optimization using different calculation methods suggests that Hartree-Fock (HF)/6-31G is the best method to describe the most stable ketorolac structure. Docking studies have been performed on AutoDock and Gaussian software. Molecular docking results were used to predict the separation of ketorolac enantiomers in the AGP (alpha-1-acid-glycoprotein) chiral column by comparing the binding energies and types of interaction. To ensure the accuracy of the results, not only specific docking was performed, but blind docking was also conducted in this study. The results of the study show that the binding energy of S-ketorolac is more negative than that of R-ketorolac, indicating that stronger interaction between S-ketorolac and AGP occurs. Therefore, the R-ketorolac will be eluted first from the AGP column followed by S-ketorolac. As expected, this prediction is in good agreement with the experimental results of the separation of ketorolac enantiomers.

• Periodical: Advances in Science and Technology (Volume 115)
• Pages: 29-35
• DOI: https://doi.org/10.4028/p-v22c3x
• Online since: August 2022
• Authors: Rosati Sabdowati, Dwi Siswanta, Dadan Hermawan, Mudasir Mudasir*
• Keywords: AGP Column, Chiral Separation, Chromatography, Ketorolac, Molecular Docking

References

[1] M.M. Buckley, R.N. Brogden, Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential, Drugs. 39 (1) (1990) 86–109.

DOI: 10.2165/00003495-199039010-00008

[2] E. Mroszczak, D. Combs, M. Chaplin, I. Tsina, T. Tarnowski, C. Rocha, Y. Tam, A. Boyd, J. Young, L. Depass, Chiral kinetic and dinamics of ketorolac, J. Clin. Pharmacol. 36 (6) (1996) 521- 539.

DOI: 10.1002/j.1552-4604.1996.tb05042.x

[3] K.R. Ing-Lorenzini, J.A. Desmeules, M. Bessona, J. Veuthey, P. Dayer, Y. Daali, Two-dimensional liquid chromatography–ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic study, J. Chromatogr. A. 1216 (18) (2009) 3851–3856.

DOI: 10.1016/j.chroma.2009.02.071

[4] B.L. Strom, J.A. Berlin, J.L. Kinman, P.W. Spitz, S. Hennessy, H. Feldman, S. Kimmel, J.L. Carson, Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study, JAMA. 275 (5) (1996) 376–382.

DOI: 10.1097/00132586-199702000-00029

[5] M. Singh, R. Bhushan, Thin-layer chromatographic enantioresolution of (RS)-ketorolac using L-amino acids as chiral additive in stationary phase, J. Planar Chromat. 32 (6) (2019) 475–479.

DOI: 10.1556/1006.2019.32.6.5

[6] Y. He, Y. Wu, L. Cheng, S. He, Q. Wang, H. Wang, Y. Ke, Separation of ketorolac enantiomers on polysaccharide-based chiral stationary phases using a polar organic mobile phase, Sep. Sci. Plus. 1 (2018) 351–358.

DOI: 10.1002/sscp.201800048

[7] M. Pérez-Venegas, A.M. Rodríguez-Treviño, E. Juaristi, Dual mechanoenzymatic kinetic resolution of (±)-ketorolac, ChemCatChem. 12 (6) (2020) 1782–1788.

DOI: 10.1002/cctc.201902292

[8] K.S. Dubey, J. Hemantha, C.K. Venkatesh K., R.N. Saha, S. Pasha, New chiral reverse phase HPLC method for enantioselective analysis of ketorolac using chiral AGP column, J. Pharm. Anal. 2 (6) (2012) 462–465.

DOI: 10.1016/j.jpha.2012.07.006

[9] Hidayah, Validation of the analysis method of ketorolac chiral compound from pharmaceutical preparation using HPLC method, Skripsi, (2020).

[10] E.S. Nurhidayah, A.L. Ivansyah, M.A. Martoprawiro, M.A. Zulfikar, A molecular docking study to predict enantioseparation of some chiral carboxylic acid derivatives by methyl-β- cyclodextrin, J. Phys. Conf. Ser. 1013 (1) (2018) 012203.

DOI: 10.1088/1742-6596/1013/1/012203

[11] G. Fernández-Ballester, A. Fernández-Carvajal, J.M. González-Ros, A. Ferrer-Montiel, Ionic channels as targets for drug design: a review on computational methods, Pharmaceutics. 3 (4) (2011) 932–953.

DOI: 10.3390/pharmaceutics3040932

[12] S. Bua, L.D.C. Mannelli, D. Vullo, C. Ghelardini, G. Bartolucci, A. Scozzafava, C.T. Supuran, F. Carta, Design and synthesis of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs-CAIs) for the treatment of rheumatoid arthritis, J. Med. Chem. 60 (3) (2017) 1159–1170.

DOI: 10.1021/acs.jmedchem.6b01607

[13] K. Mena-Ulecia, W. Tiznado, J. Caballero, Study of the differential activity of thrombin inhibitors using docking, QSAR, molecular dynamics, and MM-GBSA, PloS One. 10 (11) (2015) e0142774.

DOI: 10.1371/journal.pone.0142774

[14] B. Amul, S. Muthu, M. Raja, S. Sevvanthi, Molecular structure, spectroscopic (FT-IR, FT-Raman, NMR, UV-VIS), chemical reactivity and biological examinations of Ketorolac, Journal of Molecular Structure. 1210 (2020) 128040.

DOI: 10.1016/j.molstruc.2020.128040

[15] L.D.C. Mannelli, D. Bani, A. Bencini, M.L. Brandi, L. Calosi, M. Cantore, A.M. Carossino, C. Ghelardini, B. Valtancoli, P. Failli, Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats, Mediat. Inflamm. (2013) 905360.

DOI: 10.1155/2013/905360

[16] A. Barakat, H.J. Al-Najjar, A.M. Al-Majid, S.M. Soliman, Y.N. Mabkhot, M.R. Shaik, H.A. Ghabbour, H. Fun, Synthesis, NMR, FT-IR, X-ray structural characterization, DFT analysis and isomerism aspects of 5-(2,6-dichlorobenzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione, Spectrochim. Acta A Mol. Biomol. Spectrosc. 147 (2015) 107–116.

DOI: 10.1016/j.saa.2015.03.016

[17] N.F. Roslan, S.F.Z. Mustafa, H. Maarof, S.N.Md. Ajeman, W.A.W Ibrahim, Molecular docking and density functional theory calculations of vinpocetine and teicoplanin aglycone chiral selector, J. Incl. Phenom. Macrocycl. Chem. 98 (2020) 187–195.

DOI: 10.1007/s10847-020-01015-9

[18] S.S.W. Waskitha, F.E. Mulyana, N.F. Riza, Y.M. Stansyah, I. Tahir, T.D. Wahyuningsih, QSAR Approach and synthesis of chalcone derivatives as antimalarial compound against Plasmodium Falciparum 3D7 Strain, Rasayan J. Chem. 14 (2021) 2363–2370.

DOI: 10.31788/rjc.2021.1445867

[19] T. Lengauer, M.Rarey, Computational methods for biomolecular docking, Curr. Opin. Struct. Biol. 6 (3) (1996) 402–406.